| Literature DB >> 32842680 |
Tomoya Fujie1, Akane Takahashi2, Musubu Takahashi2, Takato Hara1, Asuka Soyama2, Kosho Makino2, Hideyo Takahashi2, Chika Yamamoto1, Yoshito Kumagai3, Hiroshi Naka4, Toshiyuki Kaji2.
Abstract
As toxic substances can enter the circulating blood and cross endothelial monolayers to reach parenchymal cells in organs, vasEntities:
Keywords: bio-organometallics; copper diethyldithiocarbamate; cystathionine γ-lyase; endothelial cell; hypoxia-inducible factor-1; mitogen-activated protein kinase
Mesh:
Substances:
Year: 2020 PMID: 32842680 PMCID: PMC7503448 DOI: 10.3390/ijms21176053
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Expression of reactive sulfur species-producing enzymes in dense and sparse vascular endothelial cells after treatment with copper diethyldithiocarbamate (Cu10). (a) Structure of Cu10. (b) Levels of cystathionine γ-lyase (CSE) protein in dense (upper panels) and sparse (lower panels) cell cultures after treatment with Cu10. The ratio to the intensity of CSE to that of glyceraldehyde-3-phosphate dehydrogenase (GAPDH); values are mean ± SE of three replicates from three independent experiments. (c) Levels of CSE mRNA in dense (left panel) and sparse (right panel) cell cultures after treatment with Cu10. (d) Levels of cystathionine β-synthase (CBS), 3-mercaptopyruvate sulfurtransferase (3-MST), and cysteinyl-tRNA synthetase (CARS2) protein (left panels) and mRNA (right panels) in dense (upper panels) and sparse (lower panels) cell cultures after treatment with Cu10. The results of the densitometric analysis are shown in Figure S1. Dense cultures of bovine aortic endothelial cells were treated with Cu10 (1, 2, 5, 8, or 10 µM) for 24 h (left panels) or with Cu10 (5 µM) for 4, 8, 12, and 24 h (right panels). ○, Control, ●, Cu10 treatment. Values are mean ± SE of three technical replicates. Significant difference from corresponding control, * p < 0.05; ** p < 0.01. Sparse cultures of bovine aortic endothelial cells were treated with Cu10 (0.1, 0.2, 0.5, 0.8, or 1.0 µM) for 24 h (left panels) or with Cu10 (5 µM) for 4, 8, 12, and 24 h (right panels). ○, Control, ●, Cu10 treatment. Values are mean ± SE of three technical replicates. Significant difference from corresponding control, * p < 0.05; ** p < 0.01.
Figure 2CSE mRNA level in vascular endothelial cells after treatment with Na01, Zn01, Ni06, CuSO4, or Cu10 analogs. (a) Structures of Cu10, Na01, Zn01, Fe05, and Ni06. (b) CSE mRNA level. Dense cultures of bovine aortic endothelial cells were incubated with CuSO4, Na01, Zn01, Fe05, Ni06, or Cu10 (5 µM each) for 12 h. Values are mean ± SE of three technical replicates. ** Significant difference from the control, p < 0.01. (c) Structure of Cu36, Cu38, Cu40, Cu42, Cu50, and Cu52. (d) CSE mRNA level. Dense cultures of bovine aortic endothelial cells were treated with Cu36, Cu38, Cu40, Cu42, Cu50, Cu52, or Cu10 (5 µM each) for 12 h. Values are mean ± SE of three technical replicates. Significant difference from control, * p < 0.05; ** p < 0.01.
Figure 3Possible involvement of the mitogen-activated phosphate kinase (MAPK) pathway in inducing CSE transcription with Cu10. (a) Phosphorylation of extracellular signal-regulated kinase 1/2 (ERK1/2), p38 MAPK, and c-jun N-terminal kinase (JNK) in vascular endothelial cells after treatment with Cu10. Dense cultures of bovine aortic endothelial cells were treated with Cu10 (5 µM) for 0.5, 1, 1.5, 2, 3, 4, and 6 h (left panel) or with Cu10 (1, 2, 3, 5, and 10 µM) for 3 h (right panel). The results of the densitometric analysis were shown in Figure S2. (b) Possible involvement of MAPK pathways in the induction of CSE transcription in vascular endothelial cells treated with Cu10. Dense cultures of bovine aortic endothelial cells were pretreated with the ERK1/2 inhibitor PD98059, the p38 MAPK inhibitor SB203580, or the JNK inhibitor SP600125 (10 and 20 µM each) for 3 h, then treated with (■) or without (□) Cu10 (5 µM) for 12 h. ** Significant difference from the corresponding control, p < 0.01. ## Significant difference from the corresponding vehicle control (no Cu10), p < 0.01. (c) Possible involvement of epidermal growth factor receptor (EGFR) in the induction of CSE transcription in vascular endothelial cells treated with Cu10. Dense cultures of bovine aortic endothelial cells were pretreated with the EGFR inhibitor PD153035 (10 and 20 µM) for 3 h, then treated with (■) or without (□) Cu10 (5 µM) for 12 h. Values are mean ± SE of three technical replicates. ## Significant difference from the corresponding vehicle control (no Cu10), p < 0.01.
Figure 4Possible involvement of hypoxia signaling in induction of CSE transcription by Cu10. (a) hypoxia-inducible factor (HIF)-1α activation by Cu10. Dense cultures of bovine aortic endothelial cells were treated with Cu10 (1, 2, 5, and 10 µM) or CoCl2 (100 µM) for 3 h. CoCl2 was used as a positive control. The results of the densitometric analysis are shown in Figure S3. (b) HIF-1α and HIF-1β mRNAs in vascular endothelial cells after siRNA-mediated knockdown of HIF-1α and HIF-1β, respectively. Subconfluent cultures of bovine aortic endothelial cells transfected with either the control, HIF-1α, or HIF-1β siRNA for 12 h and treated with Cu10 (5 and 10 µM) for 12 h. Values are mean ± SE of three technical replicates. ** Significant difference from the corresponding siControl, p < 0.01. (c) Possible involvement of HIF-1α and HIF-1β in the induction of CSE transcription in vascular endothelial cells after Cu10 treatment. Subconfluent cultures of bovine aortic endothelial cells transfected with either the control, HIF-1α, or HIF-1β siRNA for 12 h and treated with Cu10 (5 and 10 µM) for 12 h. Values are mean ± SE of three technical replicates. Significant difference from the corresponding siControl, * p < 0.05; ** p < 0.01. Significant difference from the corresponding vehicle treated control (no Cu10), # p < 0.05; ## p < 0.01.
Figure 5Possible involvement of cyclic AMP mediated signaling and transcription factors—Nrf2, NFκB, Sp1, and ATF4—in the induction of CSE transcription by Cu10. (a) Possible involvement of cyclic AMP in the induction of CSE transcription in vascular endothelial cells treated with Cu10. Densely cultured bovine aortic endothelial were pretreated with the adenylate cyclase inhibitor SQ22536 (25 and 50 µM) (left panel) or the protein kinase A inhibitor H89 (5 and 10 µM) (right panel) for 1 h, then treated with (■) or without (□) Cu10 (5 µM) for 12 h. Values are mean ± SE of three samples. ##Significant difference from the corresponding vehicle control (no Cu10), p < 0.01. (b) Possible involvement of Nrf2 in the induction of CSE transcription in vascular endothelial cells treated with Cu10. Nrf2 protein expression (left panel). Confluent cultures of bovine aortic endothelial cells were treated with Cu10 (5 and 10 µM) for 6 h. The results of the densitometric analysis are shown in Figure S4. CSE mRNA level (right panel). Subconfluent cultures of bovine aortic endothelial cells were transfected with control or Nrf2 siRNA for 4 h and treated with (■) or without (□) Cu10 (5 and 10 µM) for 12 h. Values are mean ± SE of three technical replicates. ** Significant difference from the corresponding siControl, p < 0.01. ## Significant difference from the corresponding vehicle control (no Cu10), p < 0.01. (c) Possible involvement of NF-κB in the induction of CSE transcription in vascular endothelial cells treated with Cu10. p65 mRNA (left panel) and CSE mRNA (right panel). Subconfluent cultures of bovine aortic endothelial cells were transfected with the control or p65 siRNA for 6 h and treated with or without Cu10 (5 and 10 µM) for 12 h. Values are mean ± SE of three technical replicates. ** Significant difference from the corresponding siControl, p < 0.01. ## Significant difference from the corresponding vehicle control (no Cu10), p < 0.01. (d) Possible involvement of Sp1 in the induction of CSE transcription in vascular endothelial cells treated with Cu10. p65 mRNA (left panel) and CSE mRNA (right panel). Subconfluent cultures of bovine aortic endothelial cells were transfected with control or Sp1 siRNA for 6 h and treated with or without Cu10 (5 and 10 µM) for 12 h. Values are mean ± SE of three technical replicates. ** Significant difference from the corresponding siControl, p < 0.01. ## Significant difference from the corresponding vehicle control (no Cu10), p < 0.01. (e) Possible involvement of ATF4 in the induction of CSE transcription in vascular endothelial cells treated with Cu10. Expression of the ATF4 protein (upper panel). Dense cultures of bovine aortic endothelial cells were treated with or without Cu10 (5 µM) for 6, 12, and 24 h (upper panel). Thapsigargin (Tg) was used as a positive control. The results of the densitometric analysis are shown in Figure S5. ATF4 mRNA (lower left panel) and CSE mRNA (lower right panel). Subconfluent cultures of bovine aortic endothelial cells were transfected with the control or ATF4 siRNA for 4 h and treated with or without Cu10 (5 and 10 µM) for 12 h (lower panels). Values are mean ± SE of three technical replicates. ** Significant difference from the corresponding siControl, p < 0.01. ## Significant difference from the corresponding vehicle control (no Cu10), p < 0.01.
Figure 6Intracellular signal pathways that mediate the transcriptional induction of CSE by Cu10 in vascular endothelial cells. Involvement of activation of the MAPK (ERK1/2 and p38 MAPK) and HIF-1α/HIF-1β pathways by Cu10 was shown in the present study, although the mechanisms underlying the activation remain to be determined.
Sequences of sense and antisense siRNA strands.
| Gene | Sense (5′→3′) | Antisense (5′→3′) |
|---|---|---|
| HIF-1α | GGGAUUAACUCAGUUUGAACUdTdT | UUCAAACUGAGUUAAUCCCAUdTdT |
| HIF-1β | GAACUCUUAGGAAAGAAUAUUdTdT | UAUUCUUUCCUAAGAGUUCCUdTdT |
| Nrf2 | CCAUUGAUCUCUCUGAUCUdTdT | AGAUCAGAGAGAUCAAUCGdTdT |
| p65 | AUUGAAAGGGCUCUUUUUCAUdTdT | GAAAAAGAGCCCUUUCAAUGGdTdT |
| Sp1 | GUUUAUAUAUACAUACAUAAU | UAUGUAUGUAUAUAUAAACUA |
| ATF4 | AAUCAAACUCCUUCAAAUCdTdT | GAUUUGAAGGAGUUUGAUUdTdT |
| Negative control | UUCUCCGAACGUGUCACGUdTdT | ACGUGACACGUUCGGAGAAdTdT |
Bovine gene-specific primers for quantitative real-time PCR.
| Gene | Sense (5′→3′) | Antisense (5′→3′) |
|---|---|---|
| CSE | TCTCTTGGAGCAGTTCCATCTCCTA | GCAGCCCAGGATAAATAACCTTTTC |
| CBS | GGACTCGGTGCGGAACTACA | GGCAACACGGTCAGCGG |
| 3-MST | GCAGTGGGTGGCTGAGGC | CGATGTCAAAGAAGGCGGC |
| CARS2 | GAGGCGACAGGTACGGCAAG | CAGACTGGCGATGGTGGAAC |
| HIF-1α | GCTTGCTCATCAGTTGCCAC | GCATCCAGAAGTTTCCTCACAC |
| HIF-1β | TAAGGAGCGGTTTGCCAGGTC | TTCTGTTATGTAGGCTGTCATCTTGTTC |
| p65 | GATGGCTTCTATGAGGCTGAG | TTGTTGTTGGTCTGGATGC |
| Sp1 | CTCTAAGCATCAGGAATCAGAAGTC | TCAGAAGCCCACACATCAAAG |
| ATF4 | TGGTCTCAGACAACAGCAAG | AGCTCATCTGGCATGGTTTC |
| B2M | CCATCCAGCGTCCTCCAAAGA | TTCAATCTGGGGTGGATGGAA |